Timothy M Mayleben insider trades

Open-market stock purchases and sales by Timothy M Mayleben, Director at Marinus Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 5, 2010.

Track record: 0% of 13 scored buys are up 5% or more since purchase, averaging -88%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • MRNS Marinus Pharmaceuticals, Inc: other filings, last Feb 11, 2025
  • LABP Landos Biopharma, Inc: other filings, last May 23, 2024
  • ESPR Esperion Therapeutics, Inc: 13 buys, last Jan 28, 2021
  • LOXO Loxo Oncology, Inc: 3 sales, last Jun 13, 2018
  • ASTM Aastrom Biosciences Inc: 9 buys, last Aug 29, 2012

Get free alerts when Timothy M Mayleben files a new trade →